Haisun Zhu

Title: Haisun Zhu: Innovator in Procoagulant Antibodies

Introduction

Haisun Zhu is a prominent inventor based in Norfolk, MA (US). He has made significant contributions to the field of biomedicine, particularly in the development of procoagulant antibodies. With a total of 2 patents, his work focuses on innovative solutions for treating coagulopathies such as hemophilia A.

Latest Patents

Haisun Zhu's latest patents include groundbreaking inventions related to procoagulant antibodies. The first patent describes improved procoagulant antibodies, including bispecific antibodies that can bind to coagulation Factor IX (FIX) or its activated form, Factor IXa (FIXa). These antibodies promote Factor X (FX) activation by FIXa and offer methods and compositions for treating subjects suffering from coagulopathy. The second patent details multispecific procoagulant antibodies capable of binding to both FIX and FX, along with their activated forms. This invention also includes methods and compositions for treating coagulopathy and provides kits and methods of manufacture.

Career Highlights

Haisun Zhu is currently employed at Novo Nordisk A/S, where he continues to advance his research in the field of coagulation. His work has the potential to significantly impact the treatment of patients with bleeding disorders.

Collaborations

Haisun collaborates with notable colleagues, including Karina Thorn and Bjarne Gram Hansen. Their combined expertise contributes to the innovative research and development of new therapeutic solutions.

Conclusion

Haisun Zhu's contributions to the field of procoagulant antibodies exemplify his dedication to improving medical treatments for coagulopathies. His innovative patents and ongoing work at Novo Nordisk A/S highlight his role as a key figure in biomedical research.